J2790
J2790 – Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 6 NDCs crosswalked per 300 MCG (1500 IU) $85.125/unit ASP+6%
📋 J2790 summary
J2790 is a HCPCS Level II J-code used to bill rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.), billed per 300 MCG (1500 IU). The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2790: Hyperrho*, Rhogam Ultra-Filtered Plus, Hyperrho Full Dose
Code J2790
Billing unit 300 MCG (1500 IU) Payment limit $85.125/unit NDC-Crosswalk 6
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2790
DescriptorInjection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
Billing unit300 MCG (1500 IU)
Payment limit / unit$85.125
Est. ASP / unit$80.307 est.
Mapped NDCs6
Data periodQ3 2026
Last updated2026-08-20
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$85.125
Est. ASP / unit
$80.307 est.
Est. after 2% sequester
$83.423
HCPCS dosage
300 MCG (1500 IU)
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2014-01-01
Date added1986-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2790 = 300 mcg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2790 WITH EST. MEDICARE PAY
6 NDCs map to J2790. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($85.125/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00562-7805-01 | RhoGAM Ultra-Filtered PLUS HUMAN RHO(D) IMMUNE GLOBULIN 300 ug/1 INJECTION, SOLUTION | Kedrion | 1 POUCH in 1 CARTON (0562-7805-01) / 1 IN... | 300 ug/1 | 1 | $85.13 | — | ● Active | CMS + PDAC |
| 00562-7805-05 | RhoGAM Ultra-Filtered PLUS HUMAN RHO(D) IMMUNE GLOBULIN 300 ug/1 INJECTION, SOLUTION | Kedrion | 5 POUCH in 1 CARTON (0562-7805-05) / 1 IN... | 300 ug/1 | 5 | $425.63 | — | ● Active | CMS + PDAC |
| 00562-7805-25 | RhoGAM Ultra-Filtered PLUS HUMAN RHO(D) IMMUNE GLOBULIN 300 ug/1 INJECTION, SOLUTION | Kedrion | 25 POUCH in 1 CARTON (0562-7805-25) / 1 I... | 300 ug/1 | 25 | $2,128.13 | — | ● Active | CMS + PDAC |
| 13533-0631-02 | HYPERRHO FULL DOSE RHO(D) IMMUNE GLOBULIN (HUMAN) 1500 [iU]/mL SOLUTION | GRIFOLS | 1 SYRINGE in 1 CARTON (13533-631-02) / 1... | 1500 [iU]/mL | 1 | $85.13 | — | ● Active | CMS + PDAC |
| 13533-0631-11 | HYPERRHO FULL DOSE RHO(D) IMMUNE GLOBULIN (HUMAN) 1500 [iU]/mL SOLUTION | GRIFOLS | 10 CARTON in 1 CARTON (13533-631-11) / 1... | 1500 [iU]/mL | 10 | $851.25 | — | ● Active | CMS + PDAC |
| 00562-7805-00 | RHOGAM ULTRA-FILTERED PLUS (INNER PACK,PF) 300 MCG | Unknown | — | — | 1 | $85.13 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$2.2K
Claims
29
Beneficiaries
28
Spend / beneficiary
$79.66
Spend / claim
$76.92
Trend by period
Where J2790 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #743 of 824
#738
PROCHLORPERAZINE EDI... J0780
$2.5K
#739
PREDNISOLONE SODIUM... J7510
$2.4K
#740
BCG (TICE STRAIN)(90... 90586
$2.4K
#741
DEXTROSE 5%-0.9% NAC... J7042
$2.4K
#742
PELLOGRAFT, PER SQ C... Q4320
$2.2K
#743
HYPERRHO* J2790
$2.2K
#744
POLOCAINE-MPF* J0670
$2.1K
#745
NAFCILLIN SODIUM J2290
$2K
#746
AZACTAM* J0457
$2K
#747
FLUPHENAZINE DECANOA... J2680
$1.9K
#748
ATIVAN* J2060
$1.8K
Total claims — #745 of 824
#740
TIGAN J3250
31
#741
LEVOTHYROXINE SODIUM... J0650
30
#742
TEMODAR J9328
30
#743
CYGNUS, PER SQ CM** Q4170
30
#744
BRIXADI(J0577) J0577
29
#745
HYPERRHO* J2790
29
#746
ZIEXTENZO Q5120
29
#747
HYPERHEP B* 90371
28
#748
SPEVIGO J1747
28
#749
TIGECYCLINE* J3243
28
#750
VFEND IV* J3465
28
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $2.2K | 28 | 29 | $79.66 | $76.92 |
| 2025 (Q1-Q4) | $9.6K | 118 | 120 | $81.25 | $79.89 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
—
Medicare paid
$7.1K
Submitted services
—
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J2790
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
6 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2790 billing FAQ
What is HCPCS code J2790?
J2790 is a HCPCS Level II J-code used to bill Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2790?
One unit of J2790 represents 300 MCG (1500 IU). Report the number of units equal to the dose administered divided by 300 MCG (1500 IU).
How many units of J2790 should I bill?
Divide the dose administered by the code's unit size (300 MCG (1500 IU)) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2790?
The Medicare Part B payment limit is $85.125 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $83.423 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2790?
6 NDCs currently map to J2790 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2790 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.